| ViraEpi843 | Epstein barr virus (EBV) | Wp | NA | 14015 | 14015 | Hyper | 72.72% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi844 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 90.90% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi845 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi846 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi847 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi848 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi849 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hyper | 90.90% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi850 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Hyper | 72.72% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi851 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | Hyper | 63.63% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi852 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hyper | 81.81% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi853 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hyper | 63.63% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi854 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Hyper | 72.72% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi855 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Hyper | 72.72% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi856 | Epstein barr virus (EBV) | Wp | NA | 14296 | 14296 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi859 | Epstein barr virus (EBV) | Wp | NA | 14445 | 14445 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi860 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi862 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hyper | 80% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi863 | Epstein barr virus (EBV) | Wp | NA | 14015 | 14015 | Hyper | 90% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi864 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi865 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi866 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi867 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi868 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi869 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hyper | 100% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi870 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Hyper | 80% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |